Back
Accenture PLC 10K Form
Sell
38
ACN
Accenture PLC
Last Price:
303.54
Seasonality Move:
3.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-03-21 | 10Q | ACN/Accenture PLC Quarterly |
2023-12-19 | 10Q | ACN/Accenture PLC Quarterly |
2023-06-22 | 10Q | ACN/Accenture PLC Quarterly |
2023-03-23 | 10Q | ACN/Accenture PLC Quarterly |
2022-12-16 | 10Q | ACN/Accenture PLC Quarterly |
2022-06-23 | 10Q | ACN/Accenture PLC Quarterly |
Receive ACN News And Ratings
See the #1 stock for the next 7 days that we like better than ACN
ACN Financial Statistics
Sales & Book Value
Annual Sales: | $64.11B |
---|---|
Cash Flow: | $1.99B |
Price / Cash Flow: | 22.02 |
Annual Sales: | $43.13 |
Price / Book: | 7.04 |
Profitability
EPS (TTM): | 11.03000 |
---|---|
Net Income (TTM): | $7.03B |
Gross Margin: | $20.73B |
Return on Equity: | 26.55% |
Return on Assets: | 13.95% |
Accenture PLC Earnings Forecast
Key Accenture PLC Financial Ratios
- The Gross Profit Margin over the past 23 years for ACN is 32.34%.
- The Selling, General & Administrative Expenses for ACN have been equal to 16.94% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.69% of Operating Income.
- The Net Earning history of ACN is 10.72% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 18 years.
Accenture PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | IT Services |
Sector: | Information Technology |
Current Symbol: | ACN |
CUSIP: | G1151C |
Website: | accenture.com |
Debt
Debt-to-Equity Ratio: | 0.01 |
---|---|
Current Ratio: | 1.26 |
Quick Ratio: | 1.13 |
Price-to-Earnings
Trailing P/E Ratio: | 28.19 |
---|---|
Forward P/E Ratio: | 22.99 |
ACN Technical Analysis vs Fundamental Analysis
Sell
38
Accenture PLC (ACN)
is a Sell
Is Accenture PLC a Buy or a Sell?
-
Accenture PLC stock is rated a Sell
The current Accenture PLC [ACN] share price is $303.59. The Score for ACN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.